|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The shear strength of trabecular bone from the femur, and some factors affecting the shear strength of the cement - bone interface 显示文摘 | Lee AJC Ling RSM | 1978 | Arch Orthop Trauma Surg1978，92，： | 1 |
| 2 | QT dispersion and myocardial viability in patients after acute myocardial infarction显示文摘 | Kosmala W Przewlocka-Kosmala M Halawa B | 2004 | Int J Cardiol2004，94，23： | 1 |
| 3 | Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant显示文摘AIM To consolidate the present evidence of effectiveness in renal functioning and graft survival following early introduction of mammalian target of rapamycin(m TOR) inhibitors with or without calcineurin inhibitors(CNIs) in renal transplant recipients.METHODS We analysed the current literature following PROSPERO approval describing the role of immunosuppressive agent, m TOR inhibitors as an alternative to CNI within six months of renal transplant by searching the Pub Med, EMBASE, Cochrane, Crossref, and Scopus using Me SH terms. RESULTS Six articles of early withdrawal of CNI and introduction of m TOR-inhibitors within six months of renal transplantation were sought. Glomerular filtration rate(GFR) and serum creatinine were significantly better in m TOR inhibitor group with equivalent survival at 12 mo, even though Biopsy Proven Acute rejection was significantly higher in m TOR-inhibitor group. CONCLUSION The evidence reviewed in this meta-analysis suggests that early introduction m TOR-inhibitors substantial CNI minimization. The m TOR inhibitors such as everolimus and sirolimus, due to their complementary mechanism of action and favourable nephrotoxicity profile; better glomerular filtration, lower serum creatinine with equivalent survival. Having said that, due to the higher rejection rate, may influence the use of these regimens to patients with moderate to high immunological risk patients. | Jayant Kumar Isabella Reccia Tomokazu Kusano Bridson M Julie Ajay Sharma Ahmed Halawa | 2017 | World Journal of Transplantation2017，7，2： | 1 |
| 4 | The shear strength of trabecular bone from the femur and some factors affecting the cementbone interface显示文摘 | Lee AJ Ling RS | 1978 | Acta Orthop Trauma Surg1978，92，1： | 1 |
| 5 | Aortic dissection and its endovascular management显示文摘 | Hinchliffe RJ Halawa M Holt PJ | 2008 | J Cardiovasc Surg(Torino)2008，49，4： | 1 |
| 6 | Aortic dissection and its endovascular management 显示文摘 | Hinchliffe RJ Halawa M Holt PJ | 2008 | J Cardiovasc Surg (Torino)2008，49，4： | 1 |
| 7 | Aortic dissection and its endovascular management显示文摘 | Hinchliffe RJ Halawa M Holt PJ | 2008 | J Cardiovase Surg (Torino)2008，49，4： | 1 |
| 8 | The shear strength of trabecular bone from the femur, and some factors affecting the shear strength of the cement-bone interface显示文摘 | Halawa M Lee AJC Ling RSM | 1978 | Arch Orthop Trauma Surg1978，92，： | 1 |
| 9 | Aortic dissection and its endovascular management 显示文摘 | Hinchliffe R J Halawa M Holt PJ | 2008 | J Cardiovasc Surg ( Torino)2008，49，4： | 1 |
| 10 | Aortic dissection and its endovascular management显示文摘 | Hinchlife RJ Halawa M Holt PJ | 2008 | J Cardiovasc Surg(Torino)2008，49，4： | 1 |
| 11 | QT dispersion and myocardial viability in patients after acute myocardial infarction显示文摘 | Kosmala W Przewlocka-Kosmala M Halawa B | 2004 | Int J Cardiol2004，94，23： | 1 |
| 12 | “Contrast nephropathy” in renal transplantation:Is it real?显示文摘The risk of contrast-induced nephropathy(CIN) in renal transplant recipients is increased in diabetics, patients with impaired basal kidney function, patients in shock, patients presenting with acute emergency and in old age recipients. Approximately one-third of all hospitalized patients with acute kidney injury is attributed to CIN. In the United States, it is the third leading cause of hospital-acquired renal failure. Therefore, efforts should be directed to minimize CIN-related morbidity and mortality as well as to shorten hospital stay. While the role of peri-procedural prophylactic hydration with saline is unequivocal; the use of acetyl cysteine is not based on robust evidence. The utility of theophylline, aminophylline, calcium channel blockers, natriuretic peptide, and diuretics does not have proven role in attenuating CIN incidence. We aim to analyze the evidence for using various protocols in published literature to limit CIN-associated morbidity and mortality, particularly during surveillance of the renal allograft survival. | Fedaey Mohammed Abbas Bridson M Julie Ajay Sharma Ahmed Halawa | 2016 | World Journal of Transplantation2016，6，4： | 1 |
| 13 | Aortic dissection and its endovascular management显示文摘 | Hinchliffe RJ Halawa M Holt PJ | 2008 | J Cardiovasc Surg (Torino)2008，49，4： | 1 |
| 14 | Stability and calibration of platinum/palladium thermocouples following heat treatment 显示文摘 | Abdekaziz Y A Megahed F M Halawa M M | 2004 | Measurement2004，35，4： | 1 |
| 15 | QT dispersion and myocardial viability in patients after acute myocardial infarction显示文摘 | Kosmala W Przewlocka-Kosmala M Halawa B | 2004 | Int J Cardiol2004，94，23： | 1 |
| 16 | Improving limb salvage rate in diabetic patients with critical leg ischaemia using a multidisciplinary approach显示文摘 | Zayed H Halawa M Maillardet L | 2008 | Int J Clin Pract2008，，： | 1 |
| 17 | Aortic dissection and its endovascular management显示文摘 | Hinchliffe RJ Halawa M Holt PJ | 2008 | J Cardiovase Surg ( Torino )2008，49，4： | 1 |
| 18 | QT dispersion andmyocardial viability in patients after acute myocardial infarclion显示文摘 | Kosmala W Przewlocka-Kosmala M Halawa B | 2004 | Int J Caniiol2004，94，23： | 1 |
| 19 | QT dispersion and myocardial viability in patients afteracute myocardial infarction显示文摘 | Kosmala W Przewlocka-Kosmala M Halawa B | 2004 | Int J Cardiol2004，94，23： | 1 |
| 20 | Corticosteroid minimization in renal transplantation:Careful patient selection enables feasibility显示文摘AIM To explore the benefits and harms of corticosteroid(CS) minimization following renal transplantation. METHODS CS minimization attempts to improve cardiovascular risk factors(hypertension, diabetes, dyslipidemia), to enhance growth in children, to ameliorate bone disease and to lead to better compliance with immunosuppressive agents. Nevertheless, any benefit must be carefully weighed against the reduction in net immunosuppression and the potential harm to renal allograft function and survival. RESULTS Complete CS avoidance or very early withdrawal(i.e., no CS after post-transplant day 7) seems to be associated with better outcomes in comparison with later withdrawal. However, an increased incidence of CS-sensitive acute rejection has been observed with all CS minimization strategies. Among the prerequisites for the safe application of CS minimization protocols are the administration of induction immunosuppression and the inclusion of calcineurin inhibitors in maintenance immunosuppression regimens. CONCLUSION Transplant recipients at low immunological risk(primary transplant, low panel reactive antibodies) arethought as optimal candidates for CS minimization. CS avoidance may also be undesirable in patients at risk for glomerulonephritis recurrence or with severe delayed graft function and prolonged cold ischemia time. Thus, CS minimization is not yet ready for implementation in the majority of transplant recipients. | Georgios Vlachopanos Julie M Bridson Ajay Sharma Ahmed Halawa | 2016 | World Journal of Transplantation2016，6，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员